141 related articles for article (PubMed ID: 35228386)
1. Application of Quantitative NMR (qHNMR) towards Establishment of Pharmaceutical Reference Standard; A Case of a Ticagrelor Process Impurity.
Bhavaraju S; Sreerama SG; Taylor D; Rau S
Chem Pharm Bull (Tokyo); 2022; 70(3):226-229. PubMed ID: 35228386
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical analysis by NMR can accommodate strict impurity thresholds: The case of choline.
Achanta PS; Niemitz M; Friesen JB; Tadjimukhamedov FK; Bzhelyansky A; Giancaspro GI; Chen SN; Pauli GF
J Pharm Biomed Anal; 2022 May; 214():114709. PubMed ID: 35339885
[TBL] [Abstract][Full Text] [Related]
3. Quantitative
Guo Q; Li Z; Shen L; Xiao Y; Cheng Z
Phytochem Anal; 2021 Jan; 32(1):104-111. PubMed ID: 33128329
[TBL] [Abstract][Full Text] [Related]
4. Forced degradation and impurity profiling: recent trends in analytical perspectives.
Jain D; Basniwal PK
J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
[TBL] [Abstract][Full Text] [Related]
5. Importance of purity evaluation and the potential of quantitative ¹H NMR as a purity assay.
Pauli GF; Chen SN; Simmler C; Lankin DC; Gödecke T; Jaki BU; Friesen JB; McAlpine JB; Napolitano JG
J Med Chem; 2014 Nov; 57(22):9220-31. PubMed ID: 25295852
[TBL] [Abstract][Full Text] [Related]
6. Validation of a generic quantitative (1)H NMR method for natural products analysis.
Gödecke T; Napolitano JG; Rodríguez-Brasco MF; Chen SN; Jaki BU; Lankin DC; Pauli GF
Phytochem Anal; 2013; 24(6):581-97. PubMed ID: 23740625
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical impurity identification: a case study using a multidisciplinary approach.
Alsante KM; Boutros P; Couturier MA; Friedmann RC; Harwood JW; Horan GJ; Jensen AJ; Liu Q; Lohr LL; Morris R; Raggon JW; Reid GL; Santafianos DP; Sharp TR; Tucker JL; Wilcox GE
J Pharm Sci; 2004 Sep; 93(9):2296-309. PubMed ID: 15295790
[TBL] [Abstract][Full Text] [Related]
8. Levothyroxine sodium revisited: A wholistic structural elucidation approach of new impurities via HPLC-HRMS/MS, on-line H/D exchange, NMR spectroscopy and chemical synthesis.
Ruggenthaler M; Grass J; Schuh W; Huber CG; Reischl RJ
J Pharm Biomed Anal; 2017 Feb; 135():140-152. PubMed ID: 28024262
[TBL] [Abstract][Full Text] [Related]
9. Pharmaceutical impurities and degradation products: uses and applications of NMR techniques.
Maggio RM; Calvo NL; Vignaduzzo SE; Kaufman TS
J Pharm Biomed Anal; 2014 Dec; 101():102-22. PubMed ID: 24853620
[TBL] [Abstract][Full Text] [Related]
10. A compatibility study of a secondary amine active pharmaceutical ingredient with starch: identification of a novel degradant formed between desloratadine and a starch impurity using LC-MS(n) and NMR spectroscopy.
Yu X; Buevich AV; Li M; Wang X; Rustum AM
J Pharm Sci; 2013 Feb; 102(2):717-31. PubMed ID: 23242759
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of 2-Azaspiro [4,5] Decan-3-One (Impurity A) in Gabapentin Determination Method Using qNMR Spectroscopy.
Kuz'mina NE; Moiseev SV; Khorolskiy MD; Lutceva AI
Molecules; 2021 Mar; 26(6):. PubMed ID: 33809747
[TBL] [Abstract][Full Text] [Related]
12. Semi-preparative high-resolution recycling liquid chromatography.
Gritti F; Basile M; Cormier S; Fogwill M; Gilar M; McDonald T; Riley F; Yan Q
J Chromatogr A; 2018 Sep; 1566():64-78. PubMed ID: 29958681
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous relative UV response determination of known liquid drug product degradants by NMR spectroscopy.
Samuels ER; Wang T
J Pharm Biomed Anal; 2022 May; 213():114665. PubMed ID: 35217258
[TBL] [Abstract][Full Text] [Related]
14. Identification, isolation, characterization and response factor determination of process-related impurity in meprobamate drug substance.
Karthikeyan K; Arularasu GT; Murali V; Pillai KC
J Pharm Biomed Anal; 2011 Jan; 54(1):208-12. PubMed ID: 20727702
[TBL] [Abstract][Full Text] [Related]
15. NMR reveals an undeclared constituent in custom synthetic peptides.
Choules MP; Bisson J; Simmler C; McAlpine JB; Giancaspro G; Bzhelyansky A; Niemitz M; Pauli GF
J Pharm Biomed Anal; 2020 Jan; 178():112915. PubMed ID: 31671336
[TBL] [Abstract][Full Text] [Related]
16. Characterization of unknown impurities in Coenzyme Q
Deng Y; Chen X; Wang L; Peng X; Lin M
J Pharm Biomed Anal; 2019 Oct; 175():112771. PubMed ID: 31330281
[TBL] [Abstract][Full Text] [Related]
17. Accurate determination of reference materials and natural isolates by means of quantitative (1)h NMR spectroscopy.
Frank O; Kreissl JK; Daschner A; Hofmann T
J Agric Food Chem; 2014 Mar; 62(12):2506-15. PubMed ID: 24559241
[TBL] [Abstract][Full Text] [Related]
18. Quantum Mechanical Quantitative Nuclear Magnetic Resonance Enables Digital Reference Standards at All Magnetic Fields and Enhances qNMR Sustainability.
Nishizaki Y; Sugimoto N; Miura T; Asakura K; Suematsu T; Korhonen SP; Lehtivarjo J; Niemitz M; Pauli GF
Anal Chem; 2024 Jun; 96(24):9790-9798. PubMed ID: 38829167
[TBL] [Abstract][Full Text] [Related]
19. Four process-related potential new impurities in ticagrelor: Identification, isolation, characterization using HPLC, LC/ESI-MS(n), NMR and their synthesis.
Kumar N; Devineni SR; Gajjala PR; Gupta DK; Bhat S; Kumar R; Dubey SK; Kumar P
J Pharm Biomed Anal; 2016 Feb; 120():248-60. PubMed ID: 26760243
[TBL] [Abstract][Full Text] [Related]
20. Determination of relative response factors for chromatographic investigations using NMR spectrometry.
Webster GK; Marsden I; Pommerening CA; Tyrakowski CM; Tobias B
J Pharm Biomed Anal; 2009 Jul; 49(5):1261-5. PubMed ID: 19345032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
